MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Skincare
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Medical Marijuana, Inc. CEO Dr. Stuart Titus Talks Advances in the Medical Marijuana Industry with Uptick Newswire

Medical Marijuana, Inc. CEO Dr. Stuart Titus Talks Advances in the Medical Marijuana Industry with Uptick Newswire

by adminTorusBrand | Jan 27, 2017 | Axim Biotechnologies, Company News, HempMeds Brasil, HempMeds Mexico, Media Coverage

Dr. Stuart Titus sat down with Everett Jolly of Uptick Newswire this week to discuss the ever increasing momentum driving marijuana legalization and the growth of the cannabis industry. Dr. Titus began the interview relaying recent accomplishments by Medical...
Mexico’s COFEPRIS Authorizes First Legal Import of RSHO-X™ as Part of Cancer Treatment

Mexico’s COFEPRIS Authorizes First Legal Import of RSHO-X™ as Part of Cancer Treatment

by adminTorusBrand | Jan 24, 2017 | Company News, HempMeds Mexico, Scientific Research

Cancer patient in Mexico receives approval for RSHO-X™ to treat pain associated with cancer treatments and promote general well-being. HempMeds® Mexico, a subsidiary of Medical Marijuana, Inc., announced this week that their flagship product RSHO-X™ received approval...
Medical Marijuana, Inc. President and CEO Discusses Worldwide Potential for CBD with International Business Times

Medical Marijuana, Inc. President and CEO Discusses Worldwide Potential for CBD with International Business Times

by adminTorusBrand | Jan 23, 2017 | Company News, HempMeds Mexico, Media Coverage

[vc_row][vc_column][vc_column_text] In an interview with the International Business Times, Dr. Stuart Titus revealed how THC-free RSHO™ helped spark cannabis reform in Mexico and what the next steps are for the worldwide cannabis industry. A comprehensive article...
AXIM® Biotech Begins Clinical Trial Targeting Effective Irritable Bowel Syndrome Treatment

AXIM® Biotech Begins Clinical Trial Targeting Effective Irritable Bowel Syndrome Treatment

by adminTorusBrand | Jan 18, 2017 | Axim Biotechnologies, Company News

[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies Brings Their Patented CanChew® Plus Delayed-Release CBD Chewing Gum to Clinical Trials for IBS, a $1.5B market opportunity. AXIM® Biotechnologies announced this week that the company has entered clinical trials...
HempMeds® Brasil Partners with Paragon HealthCare BR to Expand Accessibility of RSHO™

HempMeds® Brasil Partners with Paragon HealthCare BR to Expand Accessibility of RSHO™

by adminTorusBrand | Jan 10, 2017 | Company News, HempMeds Brasil

Medical Marijuana, Inc. and its subsidiary HempMeds® Brasil announced late last week that the company has signed into a distribution partnership with Paragon HealthCare BR, a leading global wholesale distributor of pharmaceutical products. This is just the latest of...
Wall Street Analysts Rank Medical Marijuana, Inc. and AXIM® Biotechnologies Among Top 10 Most Successful Cannabis Companies

Wall Street Analysts Rank Medical Marijuana, Inc. and AXIM® Biotechnologies Among Top 10 Most Successful Cannabis Companies

by adminTorusBrand | Jan 6, 2017 | Axim Biotechnologies, Company News

[vc_row][vc_column][vc_column_text] High Times Magazine features Medical Marijuana, Inc. and AXIM® Biotechnologies in article titled “10 Largest Marijuana Companies Raking in Huge Profits”. Both Medical Marijuana, Inc. and AXIM® Biotechnologies received validation of...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.